Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced Diarrhoea
Status:
Completed
Trial end date:
2019-06-27
Target enrollment:
Participant gender:
Summary
This is a double-blind, two period, two treatment crossover trial of ondansetron verses
placebo studying the effects of ondansetron in the small and large bowel, specifically its
effects on the amount of water in the gut, measured by MRI.